glp-1 approved for weight loss FDA Approves First Generic Liraglutide Indications for GLP-1/GIP RA Summary

This includes the Wegovy pill, Foundayo, and the Ozempic pill

T.SanchezJ

Get the details: #MACE #PCSK9I To view or add a comment, sign in Evolocumab can help attenuate the elevated risk of major adverse cardiovascular events that individuals with obesity and atherosclerotic cardiovascular disease (ASCVD) face, according to a prespecified analysis from the FOURIER trial published in #JACC

This can occur no matter how the weight is lost

Moreover, given the high cost of these medications and the limited access for uninsured, underinsured, or low-income individualswho may stand to benefit the mostthere is a critical need for policies that enhance access to these therapies to mitigate potential health disparities

Will stopping GLP-1s cause blood sugar problems